Top compounds associated with response to KRT86


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.5
mRNA momelotinib CTRPv2 pan-cancer AAC 0.021 0.5
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.045 0.5
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.022 0.5
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC -0.023 0.5
mRNA pac-1 CTRPv2 pan-cancer AAC -0.022 0.5
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.02 0.5
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.031 0.5
mRNA PDMP CTRPv2 pan-cancer AAC -0.023 0.5
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.5
Download CSV